Ongoing search for diagnostic biomarkers in idiopathic normal pressure hydrocephalus

被引:22
作者
Tarnaris, Andrew [1 ]
Toma, Ahmed K. [1 ]
Kitchen, Neil D. [1 ]
Watkins, Laurence D. [1 ]
机构
[1] Natl Hosp Neurol & Neurosurg, Dept Neurosurg, London WC1N 3BG, England
关键词
Alzheimer's disease; biomarkers; CSF; diagnosis; imaging; normal pressure hydrocephalus; Parkinson's disease; vascular dementia; CEREBRAL-BLOOD-FLOW; CEREBROSPINAL-FLUID FLOW; WHITE-MATTER LESIONS; SOMATOSTATIN-LIKE IMMUNOREACTIVITY; INTRACRANIAL COMPARTMENT VOLUMES; MAGNETIC-RESONANCE-SPECTROSCOPY; POSITRON-EMISSION-TOMOGRAPHY; AQUEDUCTAL CSF FLOW; PHASE-CONTRAST MR; ALZHEIMERS-DISEASE;
D O I
10.2217/BMM.09.37
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Idiopathic normal pressure hydrocephalus is a syndrome, which typically has a clinical presentation of gait/balance disturbance, often accompanied by cognitive decline and/or urinary incontinence. Its diagnosis is based on relevant history and clinical examination, appropriate imaging findings and physiological testing. The clinical picture of idiopathic normal pressure hydrocephalus may occasionally be difficult to distinguish from that of Alzheimer's dementia, subcortical ischemic vascular dementia and Parkinson's disease. The aim of this article is to systematically review the literature from the last 29 years in order to identify cerebrospinal fluid (CSF) or imaging biomarkers that may aid in the diagnosis of the syndrome. The authors concluded that no CSF or imaging biomarker is currently fulfilling the criteria required to aid in the diagnosis of the condition. However, a few studies have revealed promising CSF and imaging markers that need to be verified by independent groups. The reasons that the progress in this field has been slow so far is also commented on, as well as steps required to apply the current evidence in the design of future studies within the field.
引用
收藏
页码:787 / 805
页数:19
相关论文
共 196 条
[31]  
BRADLEY WG, 1991, AM J NEURORADIOL, V12, P31
[32]  
Bradley WG, 1998, AM J NEURORADIOL, V19, P1285
[33]   1H magnetic resonance spectroscopy in human hydrocephalus [J].
Braun, KPJ ;
Gooskens, RHJM ;
Vandertop, WP ;
Tulleken, CAF ;
van der Grond, J .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2003, 17 (03) :291-299
[34]  
Braun KPJ, 2000, NEUROL RES, V22, P51
[35]   Meningeal derived cerebrospinal fluid proteins in different forms of dementia: is a meningopathy involved in normal pressure hydrocephalus? [J].
Brettschneider, J ;
Riepe, MW ;
Petereit, HF ;
Ludolph, AC ;
Tumani, H .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (11) :1614-1616
[36]   Normal-pressure hydrocephalus: White matter lesions correlate negatively with gait improvement after lumbar puncture [J].
Bugalho, Paulo ;
Alves, Luisa .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2007, 109 (09) :774-778
[37]  
CACABELOS R, 1991, METHOD FIND EXP CLIN, V13, P455
[38]   NEUROPEPTIDE-Y CEREBROSPINAL-FLUID LEVELS IN PATIENTS WITH NORMAL-PRESSURE HYDROCEPHALUS SYNDROME [J].
CATALAN, R ;
SAHUQUILLO, J ;
POCA, MA ;
MOLINS, A ;
CASTELLANOS, JM ;
GALARD, R .
BIOLOGICAL PSYCHIATRY, 1994, 36 (01) :61-63
[39]   Unifying concept for Alzheimer's disease, vascular dementia and normal pressure hydrocephalus - a hypothesis [J].
Chakravarty, A .
MEDICAL HYPOTHESES, 2004, 63 (05) :827-833
[40]  
CHANG LH, 2000, ZHONGHUA FANG SHE XI, V25, P191